Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 4, 2023
Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with CholangiocarcinomaRikita I Hatia, Madhulika Eluri, Ernest T Hawk, et al.
Cancer Research|September 28, 2017
Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung AdenocarcinomaSmruthy Sivakumar, F Anthony San Lucas, Tina L McDowell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2018
Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2K Chang, J A Willis, J Reumers, et al.
Ebiomedicine|March 26, 2019
Genomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lungSmruthy Sivakumar, F Anthony San Lucas, Yasminka A Jakubek, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 26, 2016
Genomic Landscape of Colorectal Mucosa and AdenomasEster Borras, F Anthony San Lucas, Kyle Chang, et al.
Plos One|December 21, 2022
What Should I do and Who's to blame? A cross-national study on youth's attitudes and beliefs in times of COVID-19Elisabeth L De Moor, Ting-Yu Cheng, Jenna E Spitzer, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 1, 2020
The Performance of Colorectal Cancer Screening in Brazil: The First Two Years of the Implementation Program in Barretos Cancer HospitalDenise Peixoto Guimarães, Larissa Andreoli Mantuan, Marco Antonio de Oliveira, et al.
Nature Reviews. Cancer|October 1, 2024
Defining precancer: a grand challenge for the cancer communityJessica Faupel-Badger, Indu Kohaar, Manisha Bahl, et al.
JAMA Oncology|May 1, 2018
Immune Profiling of Premalignant Lesions in Patients With Lynch SyndromeKyle Chang, Melissa W Taggart, Laura Reyes-Uribe, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 2, 2009
Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib TrialMonica M Bertagnolli, Craig J Eagle, Ann G Zauber, et al.
Pageof 18